Gefitinib i n P retreated N on-Small-Cell L ung C ancer ( NSCLC): Analysis o f E fficacy a nd C orrelation W ith H ER2 a nd Epidermal G rowth F actor R eceptor E xpression i n L ocally Advanced o r M etastatic N SCLC